Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Intestinal Neoplasms × Simvastatin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 5 Multiple Myeloma 5 Breast Neoplasms 5 Prostatic Neoplasms 4 Colorectal Neoplasms 4 Small Cell Lung Carcinoma 3 Rectal Neoplasms 3 Neoplasms 3 Neoplasm Metastasis 3 Stomach Neoplasms 2 Pancreatic Neoplasms 2 Fibrosis 2 Colonic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Intraductal, Noninfiltrating 2 Carcinoma, Hepatocellular 2 Breast Carcinoma In Situ 2 Wilms Tumor 1 Venous Thromboembolism 1 Urinary Bladder Neoplasms 1 Tuberous Sclerosis 1 Triple Negative Breast Neoplasms 1 Thrombosis 1 Sprains and Strains 1 Smoldering Multiple Myeloma 1 Sepsis 1 Sarcoma, Ewing 1 Sarcoma, Clear Cell 1 Sarcoma 1 Rhabdomyosarcoma 1

Interventions

Irinotecan 7 Bevacizumab 7 Leucovorin 6 Fluorouracil 6 Oxaliplatin 3 Capecitabine 3 Radiotherapy 2 Levoleucovorin 2 Drug Therapy 2 Bisacodyl 2 Aspirin 2 Artesunate 2 5,10-methylenetetrahydrofolic acid 2 trametinib 1 spartalizumab 1 repotrectinib 1 pralsetinib 1 pembrolizumab 1 nazartinib 1 napabucasin 1 guadecitabine 1 encorafenib 1 canakinumab 1 camrelizumab 1 apatinib 1 XELOX 1 Ursodeoxycholic Acid 1 Trastuzumab 1 Simvastatin 1 Polyethylene Glycols 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00994903 2013-12-02

StatCol

University of Auckland, New Zealand

Phase 3 Completed

Intestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡